After IFM buy, Novartis looks to more early stage biotech M & A

After the gene therapy M&A battles of late 2018, Novartis is looking make buy up more preclinical or early stage biotechs like Boston-based IFM Tre.

Source: bizjournals.com Health Care:Physician Practices headlines - May 23, 2019 Category: American Health Authors: Allison DeAngelis Source Type: news